First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Clinical trial NCT01337154 · TERMINATED

Trial details

NCT number: NCT01337154
Sponsor: CytRx
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion Stage IV Non-small Cell Lung Cancer

Start date: 2011-04-01
Primary completion: 2013-06-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.